Phase I Trial of [ 99m Tc]Tc-maSSS-PEG 2 -RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors.

Autor: Chernov, Vladimir^1,2 (AUTHOR) chernov@tnimc.ru, Rybina, Anastasiya¹ (AUTHOR), Zelchan, Roman^1,2 (AUTHOR), Medvedeva, Anna¹ (AUTHOR), Bragina, Olga^1,2 (AUTHOR), Lushnikova, Nadejda³ (AUTHOR), Doroshenko, Artem³ (AUTHOR), Usynin, Evgeniy³ (AUTHOR), Tashireva, Liubov^4,5 (AUTHOR), Vtorushin, Sergey^4,6 (AUTHOR), Abouzayed, Ayman⁷ (AUTHOR), Rinne, Sara S.⁷ (AUTHOR), Sörensen, Jens⁸ (AUTHOR), Tolmachev, Vladimir^2,9 (AUTHOR), Orlova, Anna^2,6,10 (AUTHOR) chernov@tnimc.ru

Publikováno v: Cancers. Mar2023, Vol. 15 Issue 6, p1631. 15p.

P-185 - HER2-specific Affibody Molecule [99mTc]Tc-ZHER2:41071: phase I clinical trial

Autor: Tolmachev, Vladimir, Bragina, Olga, Chernov, Vladimir, Larkina, Maria, Rybina, Anastasiya, Zelchan, Roman, Oroujeni, Maryam, Loftenius, Annika, Orlova, Anna, Sorensen, Jens, Frejd, Fredrik

Publikováno v: In Nuclear Medicine and Biology November-December 2023 126-127 Supplement

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.